人类生殖技术：产品和全球市场

全球人类生殖技术市场规模预计将从 2021 年的 161 亿美元增长到 2027 年的 240 亿美元，预测期内的复合年增长率为 7%，从 2022 年的 171 亿美元增长到 2027 年的 240 亿美元。

避孕药具行业将从 2021 年的 93 亿美元以 7.8% 的复合年增长率增长到 2022 年的 100 亿美元和 2027 年的 147 亿美元；预计 2022 年将从 10 亿美元增长到 27 亿美元和 3.9 美元到 2027 年，以 7.5% 的速度增长 10 亿美元。

在本报告中，我们研究了全球人类生殖技术市场，提供行业概况、COVID-19 的影响、市场规模趋势和预测、细分市场和地区、专利状况、竞争环境和主要参与者。

内容

第一章介绍

第 2 章摘要亮点

第三章行业概况

• 生殖系统的结构和功能
• 生殖健康的问题和趋势
• 节育保险
• 非处方口服避孕药
• 胚胎植入前基因诊断
• 设计师宝贝
• 避孕药具的新用途
• 衰老与不孕
• 避孕贴导致死亡
• 性功能障碍和癌症
• 不孕症和癌症
• 生育治疗的信号通路
• 营销策略
• 男性避孕
• 针对女性的商品推销
• 假冒
• 多余的胚胎/胎儿
• 干细胞和其他挑战：主要观点
• 处理有争议的胚胎
• 人口统计

第 4 章生育市场

• 不孕不育的介绍和概述
• 不孕症的定义
• 不孕症的病因
• 生育能力评估
• 不明原因的不孕症
• 多胞胎
• 亚洲因素

第 5 章 COVID-19 的影响

• 简介
• COVID-19：对医疗器械和製药行业的影响
• 选择性手术被拒绝/延迟
• COVID-19 对供应链的影响
• 美国供应链：COVID-19 的影响
• 欧洲供应链：COVID-19 的影响
• 亚太地区供应链：COVID-19 的影响
• 中国：COVID-19 的影响
• COVID-19 对医疗器械和药品的影响
• COVID-19 对关键设备的影响
• COVID-19 的影响

第 6 章处理

• 生育药
• 介绍类型
• 市场收入和预测
• 生育产品的未来发展
• 竞争分析

第7章辅助生殖技术

• 简介
• 类型
• 体外受精
• 促排卵
• 鸡蛋收集
• 胞浆内单精子注射 (ICSI)
• 施肥
• 胚胎移植
• 体外受精的结果
• 礼物
• ZIFT
• 出租子宫
• 捐卵
• 冷冻胚胎
• 美国生育诊所
• 市场收入和预测
• 辅助生殖技术的未来趋势
• 竞争分析

第8章不孕症诊断

• 类型
• 尿液分析
• 市场收入和预测
• 竞争分析
• 生育诊断的未来进展
• 不孕不育市场总收入和预测

第 9 章避孕药具市场

• 简介/概述
• 药品
• 类型
• 其他避孕方案
• 市场收入和预测
• 竞争分析
• 处方设备
• 市场收入和预测
• 竞争分析
• 避孕的未来发展
• 市场总收入和预测

第 10 章性功能障碍市场

• 简介/概述
• 性功能障碍的类型
• 性功能障碍的原因
• 性功能障碍受众特征
• 药品
• 介绍类型
• 市场收入和预测
• 竞争分析
• 设备
• 市场收入和预测
• 性功能障碍的未来进展
• 市场总收入和预测

第 11 章专利

• 专利分析：按製造商
• 按公司划分的专利
• 专利：按申请
• 生育治疗
• 节育
• 性功能障碍
• 主要製造商

第 12 章总市场

• 按地区分列的全球生殖技术和产品市场
• 北美
• 欧洲
• 亚太地区
• 其他地区
• 市场规模：按类别
• 参与公司：按类别
• 市场规模：按产品类型

第 13 章竞争格局

第 14 章公司简介

• ACTAVIS, INC.
• BAYER AG
• BRISTOL-MYERS SQUIBB CO.
• CHURCH & DWIGHT COMPANY INC.
• COOPERSURGICAL INC.
• ELI LILLY & CO.
• EMD SERONO, INC.
• FERRING PHARMACEUTICALS
• GLAXOSMITHKLINE PLC
• JANSSEN PHARMACEUTICAL
• MERCK INC.
• NOVARTIS INTERNATIONAL AG
• PFIZER INC.
• PRINCETON BIOMEDITECH CORP.
• QUIDEL CORP.
• TEVA PHARMACEUTICALS.
• VIVUS INC.
• 美国生育诊所列表
• 公司列表

第 15 章附录：缩写词

Highlights:

The global market for human reproductive technologies and products is valued at $16.1 billion in 2021 and is estimated to grow from $17.1 billion in 2022 to $24 billion in 2027 with a compound annual growth rate (CAGR) of 7% for the period of 2022-2027.

The contraceptive products as a segment of the global human reproductive technologies market is valued at $9.3 billion in 2021 and is estimated to grow from $10 billion in 2022 to $14.7 billion in 2027 with a CAGR of 7.8% for the period of 2022-2027.

The infertility pharmaceuticals products as a segment of the global human reproductive technologies market is valued at $2.5 billion in 2021 and is estimated to grow from $2.7 billion in 2022 to $3.9 billion in 2027 with a CAGR of 7.5% for the period of 2022-2027

Report Scope:

The report is designed to be a comprehensive business tool to provide an in-depth look at the markets for reproductive drugs and technologies. The geographic scope of the report is global. The report reviews male and female reproductive health, presents standard pharmaceutical treatments and devices, and reviews technologies associated with reproductive health. The report also explores market size, identifies market participants, and investigates pipeline products and technologies.

The global market for reproductive technologies and products is divided into categories by treatment type and indication as follows.

Infertility market - male and female factors, pharmaceuticals, and future advancements.

• IVF.
• Assistive reproductive technologies.
• Fertility diagnostics.

Contraception - pharmaceuticals and devices.

Sexual dysfunction - pharmaceuticals and devices.

Each area is covered in detail, describing the disorder or treatment involved, identifying current products and treatments in the market in the base year 2021, measuring current market size and identifying current and potential market drivers, forecasting for 2027, assessing current and potential competitors, and identifying current competitor market shares for the base year of 2021.

Report Includes:

• 36 data tables and 22 additional tables
• An updated review of the global markets for human reproductive products and technologies
• Analyses of the global market trends, with data from 2020-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
• Evaluation and forecast the overall market size, projected growth trends, and corresponding market share analysis by treatment type, disease indication, end-user vertical, and geographic region
• In-depth information (facts and figures) concerning market drivers, market deterrents and other demographic and economic factors influencing the progress of this reproductive health market
• Discussion of the emerging technology trends, opportunities and gaps in the market estimating current and future demand for reproductive drugs and technologies, and COVID-19 implications within the marketplace
• Identification of promising new products and technologies still in the development and pipeline stage, and assess the probability that they will be commercialized successfully in the next five years
• Review of the company competitive landscape for global human reproductive drugs market, their product portfolios, global rankings, and company value share analysis based on segmental revenues
• Key merger and acquisition deals, new product launches, and other strategic alliances within the industry
• A relevant patent analysis
• Descriptive company profiles of the leading global players, including Actavis,Inc., Bayer AG, EMD Serono,Inc. and Quidel Corp.

Table of Contents

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• What's New in This Update?
• Scope of Report
• Methodology
• Information Source
• Geographic Breakdown
• Analyst's Credentials
• BCC Custom Research
• Related BCC Research Reports

Chapter 2 Summary and Highlights

• Introduction

Chapter 3 Industry Overview

• Structure and Function of the Reproductive System
• Male
• Female
• Neuroendocrine Regulation
• Menarche
• Menstruation Cycle
• Phases of Sexual Responses
• Male Sexual Response
• Female Sexual Response
• Neurohormonal Control of the Female and Male Reproductive System
• Effects of Aging
• Issues and Trends of Reproductive Health
• Contraceptive Insurance
• Over-the-Counter Birth Control Pills
• Pre-Implantation Genetic Diagnosis
• Designer Babies
• New Use for Contraceptives
• Aging and Infertility
• Death by Contraceptive Patch
• Sexual Dysfunction and Cancer
• Infertility and Cancer
• Signaling Pathway for Fertility Treatment
• Marketing Tactics
• Male Birth Control
• Merchandising Targeting Women
• Counterfeit Products
• Surplus Embryos and Fetuses
• Stem Cell and Other Controversial Issues - Selected International Views
• Controversial Disposal of Embryos
• Demographics

Chapter 4 Infertility Market

• Introduction and Overview of Infertility
• Definition of Infertility
• Etiology of Infertility
• Evaluation of Fertility
• Unexplained Infertility
• Multiple Births
• Asia Factor

Chapter 5 COVID-19 Impact

• Introduction
• COVID-19: Impact on the Medical Devices and Pharma Industries
• Decline/Delay in Elective Procedures
• COVID-19 Impact on Supply Chain
• U.S. Supply Chain: COVID-19 Impact
• European Supply Chain: COVID-19 Impact
• APAC Supply Chain: COVID-19 Impact
• China: COVID-19 Impact
• COVID-19 Impact on Medical Device and Pharmaceutical Product Segments
• COVID-19 Impact on Critical Devices
• COVID-19 Impact on Human Reproductive Technologies and Products Markets

Chapter 6 Methods of Treatment

• Fertility Pharmaceuticals
• Introduction and Types
• Market Revenues and Forecast
• Future Advancements in Infertility Products
• Competitive Analysis

Chapter 7 Assistive Reproductive Technologies

• Introduction
• Types
• IVF
• Ovulation Induction
• Oocyte Retrieval
• Intracytoplasmic Sperm Injection (ICSI)
• Fertilization
• Embryo Transfer
• Results of IVF
• GIFT
• ZIFT
• Wombs for Rent
• Oocyte Donation
• Frozen Embryos
• United States Fertility Clinics
• Market Revenues and Forecast
• Future Trends in Assistive Reproductive Technology
• Competitive Analysis

Chapter 8 Fertility Diagnostics

• Introduction
• Types
• Urine Studies
• Market Revenues and Forecast
• Competitive Analysis
• Future Advancements in Diagnostic Fertility Treatment
• Total Infertility Market Revenues and Forecast

Chapter 9 Contraception Market

• Introduction and Overview of Contraception
• Pharmaceuticals
• Types
• Other Drug Regimens for Contraception
• Market Revenues and Forecast
• Competitive Analysis
• Prescription Devices
• Market Revenues and Forecast
• Competitive Analysis
• Future Advancements in Contraception
• Total Market Revenues and Forecast

Chapter 10 Sexual Dysfunction Market

• Introduction and Overview
• Types of Sexual Dysfunction
• Causes of Sexual Dysfunction
• Demographics of Sexual Dysfunction
• Pharmaceuticals
• Introduction and Types
• Market Revenues and Forecast
• Competitive Analysis
• Devices
• Market Revenues and Forecast
• Future Advancements in Sexual Dysfunction
• Total Market Revenues and Forecast

Chapter 11 Patents

• Patent Analysis by Manufacturer
• Patent by Company
• Patents by Application
• Infertility Treatments
• Contraception
• Sexual Dysfunction
• Leading Market Manufacturers

Chapter 12 Total Market

• Total Global Market for Reproductive Technologies and Products, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Total Market Size by Category
• Industry Participants by Category
• Total Market Size by Product Type

Chapter 13 Competitive Landscape

• Competitive Analysis

Chapter 14 Company Profiles

• ACTAVIS, INC.
• BAYER AG
• BRISTOL-MYERS SQUIBB CO.
• CHURCH & DWIGHT COMPANY INC.
• COOPERSURGICAL INC.
• ELI LILLY & CO.
• EMD SERONO, INC.
• FERRING PHARMACEUTICALS
• GLAXOSMITHKLINE PLC
• JANSSEN PHARMACEUTICAL
• MERCK INC.
• NOVARTIS INTERNATIONAL AG
• PFIZER INC.
• PRINCETON BIOMEDITECH CORP.
• QUIDEL CORP.
• TEVA PHARMACEUTICALS.
• VIVUS INC.
• Selected List of U.S. Fertility Clinics
• List of Companies

Chapter 15 Appendix: Acronyms

List of Tables

• Summary Table : Global Market for Human Reproductive Technologies and Products, by Product Type, Through 2027
• Table 1 : Structural Homologues of the Male and Female Reproductive Systems
• Table 2 : U.S. Live Birth Rates, 2000-2020
• Table 3 : U.S. Population, by Selected Age Groups, and by Percent of Total Population, 2010-2030
• Table 4 : Characteristics of Women Who Have Had a Child in the Last Year, 2008 and 2010
• Table 5 : Women Who Have Had a Child in the Last Year, by Age and Labor FORCE Status, 1980-2008
• Table 6 : Contraceptive Use Share, by Type, by Age, Ethnic Group and Marital Status
• Table 7 : Birth Rate in Europe, by Country and Year, 1960-2020
• Table 8 : Selected Prescription Fertility Drugs
• Table 9 : Global Infertility Pharmaceuticals Market, Through 2027
• Table 10 : Infertility Drugs in Development
• Table 11 : Global Infertility Pharmaceutical Manufacturer Market, 2021
• Table 12 : National Summary of Assistive Reproductive Therapies in U.S., 2020
• Table 13 : National Assistive Reproductive Therapies Cycle Profile, 2019
• Table 14 : Pregnancy Success Rates, 2019
• Table 15 : Number of IVF Clinics/Centers by Selected Countries
• Table 16 : Global Assistive Reproductive Technologies Market, Through 2027
• Table 17 : Global Infertility Assistive Reproductive Products Manufacturer Market, 2021
• Table 18 : Global Fertility Diagnostics Market, by Product Type, Through 2027
• Table 19 : Global Fertility Diagnostic Manufacturer Market, 2021
• Table 20 : Global Infertility Treatments Market, by Product Type, Through 2027
• Table 21 : Contraceptive Status and Use Rates, U.S. Women Aged 15-49, 2015-2017
• Table 22 : Contraceptive Use, by Region, 2015 and 2030
• Table 23 : Most Commonly Used Oral and Transdermal Contraceptives
• Table 24 : Estrogen and Progestin Hormone Doses in Combined Birth Control Pills
• Table 25 : Potency of Different Oral Contraceptive Progestins
• Table 26 : Current Pill Problems and Choice of Pill to Switch To
• Table 27 : Global Contraceptive Pharmaceuticals Market, by Product Type, Through 2027
• Table 28 : Global Contraceptive Pharmaceutical Manufacturer Market, 2021
• Table 29 : Selected Contraceptive Device Treatments, 2021
• Table 30 : Global Contraceptive Devices Market, by Product Type, Through 2027
• Table 31 : Global Contraceptive Device Manufacturer Market, 2021
• Table 32 : Contraceptives in Development
• Table 33 : Global Contraceptive Products Market, by Product Type, Through 2027
• Table 34 : Selected Sexual Dysfunction Pharmaceutical Treatments
• Table 35 : Global Sexual Dysfunction Pharmaceuticals Market, by Product Type, Through 2027
• Table 36 : Global Sexual Dysfunction Pharmaceuticals Manufacturer Market, 2021
• Table 37 : Selected Sexual Dysfunction Device Treatments
• Table 38 : Global Sexual Dysfunction Devices Market, by Product Type, Through 2027
• Table 39 : Global Sexual Dysfunction Devices Manufacturer Market, 2021
• Table 40 : Sexual Dysfunction Drugs in Development
• Table 41 : Global Sexual Dysfunction Treatments Market, by Product Type, Through 2027
• Table 42 : Selected Manufacturer Patents for Reproductive Products and Related Technology, by Application, 2015-Present
• Table 43 : Selected Manufacturer Patents for Reproductive Products and Related Technology, by Application, 1976-Present
• Table 44 : Patent Analysis, by Selected Leading Reproductive Treatment Manufacturer, 1976-Present
• Table 45 : Global Reproductive Technologies and Products Market, Through 2027
• Table 46 : Global Reproductive Technologies and Products Market, by Region, Through 2027
• Table 47 : North American Reproductive Technologies and Products Market, by Country, Through 2027
• Table 48 : European Reproductive Technologies and Products Market, by Country, Through 2027
• Table 49 : Asia-Pacific Reproductive Technologies and Products Market, by Country, Through 2027
• Table 50 : RoW Reproductive Technologies and Products Market, Through 2027
• Table 51 : Global Reproductive Technologies and Products Market, by Region, 2021
• Table 52 : Global Reproductive Technologies and Products Market, by Region, 2027
• Table 53 : Global Reproductive Technologies and Products Market, by Product Type, Through 2027
• Table 54 : Global Reproductive Technologies and Products Market, 2019
• Table 55 : Reproductive Industry Participants, by Product Category
• Table 56 : Global Reproductive Technologies and Products Market, by Product Type, Through 2017
• Table 57 : List of Companies
• Table 58 : Acronyms Used in This Report

List of Figures

• Summary Figure A : Global Market for Human Reproductive Technologies and Products, by Product Type, 2019-2027
• Summary Figure B : Global Market Share of Human Reproductive Technologies and Products, by Product Type, 2021
• Figure 1 : U.S. Live Birth Rates, 2000-2020
• Figure 2 : U.S. Population Selected Age Groups, by Percent of Total Population, 2010-2030
• Figure 3 : Global Infertility Pharmaceutical Manufacturer Market Share, 2021
• Figure 4 : Global Infertility Assistive Reproductive Products Manufacturer Market Share, 2021
• Figure 5 : Global Fertility Diagnostic Manufacturer Market Share, 2021
• Figure 6 : Global Infertility Treatments Market, by Product Type, 2019-2027
• Figure 7 : Global Contraceptive Pharmaceuticals Manufacturer Market Share, 2021
• Figure 8 : Global Contraceptive Device Manufacturer Market Share, 2021
• Figure 9 : Global Contraceptive Products Market, by Product Type, 2019-2027
• Figure 10 : Global Sexual Dysfunction Pharmaceuticals Manufacturer Market Share, 2021
• Figure 11 : Global Sexual Dysfunction Devices Manufacturer Market Share, 2021
• Figure 12 : Global Sexual Dysfunction Treatments Market, by Product Type , 2019-2027
• Figure 13 : Global Reproductive Technologies and Products Market Share, by Region, 2021
• Figure 14 : Global Reproductive Technologies and Products Market Share, by Region, 2027
• Figure 15 : Global Reproductive Technologies and Products Market, by Product Type, 2019-2027
• Figure 16 : Number of Selected Manufacturers, by Segment, 2019
• Figure 17 : Global Reproductive Technologies and Products Market Share, 2019
• Figure 18 : Global Reproductive Technologies and Products Market, by Product Type, 2019-2027